Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GENMAB A/S (GMAB)

  • Business News
  • May 28, 2026, 06:46 UTC
  • 3
  • 1 comments

Clinical trial NCT06458439: enrollment: not set → 31 participants.

Market reaction Comment Full text

SPORTRADAR GROUP AG (SRAD)

  • Business News
  • May 28, 2026, 06:46 UTC
  • 3
  • 1 comments

SRAD Investors Have Opportunity to Join Sportradar Group AG Fraud Investigation with the Schall Law Firm

Market reaction Comment Full text

BEONE MEDICINES LTD. (IGNE)

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

Clinical trial NCT05006716: enrollment: not set → 614 participants.

Market reaction Comment Full text

VIATRIS INC (VTRS)

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

Clinical trial NCT07606625: enrollment: not set → 65 participants.

Market reaction Comment Full text

NORTHWEST BIOTHERAPEUTICS INC

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

Clinical trial NCT04312269: enrollment: not set → 70 participants.

Market reaction Comment Full text

GE HEALTHCARE TECHNOLOGIES INC. (GEHC)

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

Clinical trial NCT07609225: enrollment: not set → 15 participants.

Market reaction Comment Full text

UNITED THERAPEUTICS CORP (UTHR)

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

Clinical trial NCT03433183: enrollment: not set → 21 participants.

Market reaction Comment Full text

SPORTRADAR GROUP AG (SRAD)

  • Business News
  • May 28, 2026, 06:45 UTC
  • 3
  • 1 comments

SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

DELEK GROUP LTD. (DLEKG)

  • Business News
  • May 28, 2026, 06:44 UTC
  • 3
  • 1 comments

Events and transactions

Market reaction Comment Full text

COMMVAULT SYSTEMS INC (CVLT)

  • Business News
  • May 28, 2026, 06:42 UTC
  • 3
  • 1 comments

CVLT Investors Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • Previous
  • 1545
  • 1546
  • 1547
  • 1548
  • 1549
  • Next

Search

News categories

  • Technical Exchange News(13405)
  • Event(6229)
  • SEC News(343335)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189930)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin